Evidence-Based Medicine Guidelines
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451085/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism.
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451085/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism. Accessed March 25, 2023.
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451085/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism
Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451085/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
ID - 451085
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451085/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
